SCHEMBL1421333

SCHEMBL1421333

CN1CCN(c2ccc(-c3cc4cc(C#N)ccc4[nH]3)cn2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 3/20 0.55
CYP19A1 P11511 2/20 0.52
VCP P55072 3/20 0.51
HRH4 Q9H3N8 3/20 0.47
HTR1A P08908 1/20 0.47
ADRA2A P08913 1/20 0.47
ADRA2C P18825 1/20 0.47
HTR1D P28221 1/20 0.47
HTR2A P28223 1/20 0.47
HTR2C P28335 1/20 0.47
HTR7 P34969 1/20 0.47
HRH3 Q9Y5N1 1/20 0.47
CHEK1 O14757 2/20 0.46
PPARG P37231 1/20 0.46
TLR9 Q9NR96 1/20 0.45
TLR8 Q9NR97 1/20 0.45
TLR7 Q9NYK1 1/20 0.45
DGAT1 O75907 1/20 0.45
SOAT1 P35610 1/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1484602 0.91 TNKS (0.55) TNKSVCPHRH4HTR1AADRA2A
SCHEMBL1484608 0.84 TNKS (0.59) TNKSVCPHRH4HTR1AADRA2A
SCHEMBL1483712 0.84 TNKS (0.59) TNKSHRH4TLR9TLR8TLR7
SCHEMBL13577842 0.83 TNKS (0.58) TNKSHRH4TLR9TLR8TLR7
SCHEMBL1424190 0.83 TNKS (0.58) TNKSHRH4TLR9TLR8TLR7
SCHEMBL1423002 0.83 TNKS (0.58) TNKSCYP19A1HRH4HRH3TLR9
SCHEMBL1484021 0.81 TNKS (0.56) TNKSHRH4TLR9TLR8TLR7
SCHEMBL1484208 0.77 TNKS (0.59) TNKSHRH4TLR9TLR8TLR7
SCHEMBL1483676 0.76 TNKS (0.58) TNKSHRH4CHEK1TLR9TLR8
SCHEMBL13577843 0.76 TNKS (0.58) TNKSHRH4TLR9TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US claimed
EP-2296474-A1 NOVEL SUBSTITUTED INDOLES Merck Sharp & Dohme Corp. (US) 2011-03-23 EP claimed
WO-2009155024-A1 NOVEL SUBSTITUTED INDOLES MERCK & CO., INC. (US) 2009-12-23 WO claimed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076230-A1 Novel Substituted Indoles APP, BACE1, PSEN1 TNKS 3337/4885CYP19A1 3222/4885VCP 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.